DIAGNOS Announces the Start of the Deployment of its Pathology Detection Systems in the Retail Clinics of Farmacias Benavides, a Member of Walgreens Boots Alliance

DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the start of the deployment of its pathology detection systems in the retail clinics of Farmacias Benavides, a member of Walgreens Boots Alliance.

AI and ML News: Why SMBs Shouldn’t Be Afraid of Artificial Intelligence (AI)

“Following the signing of the agreement between DIAGNOS and Farmacias Benavides we announced in May, the hard work carried out by our team in Mexico has paid off as it already permitted the training of 30 doctors and the successful completion of the first series of deployments of our pathology detection systems in 7 retail clinics”, said Mr. Guillermo Moreno Robles, VP of DIAGNOS. “As we continue to work with Farmacias Benavides on the deployment of our systems throughout their network of over 1,100 drugstores, the initial results make us confident that the recurring and continuously growing stream of revenue generated in this sector will yield strong financial benefits to our respective organizations”, Mr. Moreno Robles concluded.

As part of its commitment to helping families improve their quality of life, and in line with its market share growth strategy, Farmacias Benavides has taken a leadership position in the area of retail clinics by increasing at a rapid rate the number of its locations where doctors provide medical consultations. As such, the Mexican population is now able to access first-class medical care, directly at their local community pharmacy, with real doctors.

Top Artificial Intelligence Insights: Determining the Potential of Your AI Algorithm Starts with Measurement

The blossoming of retail clinics was boosted by the pandemic and by a bill enacted by the Mexican health authorities that favored the opening of retail clinics. According to COFEPRIS, the government Commission responsible for regulating health related topics in Mexico, more than 10.6 million Mexicans now enjoy the benefits from this new ambulatory care environment each month.

Mr. André Larente, President of DIAGNOS mentioned, “The favorable conditions of the Mexican market and the fact that our pathology screening services are directly integrated into the chronic disease management programs offered by Farmacias Benavides, contribute to our deployment and will allow a significant increase in the popularity of our services, while raising awareness about to the significant decline in quality of life at risk of occurring when annual eye exams are not conducted. In addition, since we deploy our services in numerous retail locations, each open from 8 a.m. to 10 p.m., seven days a week, our pathology screening services will now benefit from one of the greatest possible market accessibility in the world.”

Read More About AI News : AI Innovation Supports Rural and Remote Internet Connectivity

To share your insights with us, please write to sghosh@martechseries.com]